From: Intravitreal bevacizumab (IVB) versus IVB in combination with pars plana vitrectomy for vitreous hemorrhage secondary to proliferative diabetic retinopathy: a randomized clinical trial
Group B
Baseline
8 Weeks
16 Weeks
24 Weeks
Grade 0
0
31
30
Grade 1
1
Grade 2
11
Grade 3
23
3
4